Legislators
Bills
Statements
Lobbying
Travel
Searching...- Bills
- S.4185
S.4185: RARE Act
About This Bill
- This bill was introduced in the 117th Congress
- This bill is primarily about health
- Introduced May 11, 2022
- Latest Major Action May 11, 2022
Bill Sponsor
Bill Cosponsor
Bill Version
- Introduced in Senate - May 11, 2022
Bill Summary
Retaining Access and Restoring Exclusivity Act or the RARE Act This bill specifies that the seven-year market exclusivity period for drugs for rare diseases or conditions (i.e., orphan drug exclusivity period) prohibits the approval of other drugs for the same approved use or indication with respect to the disease or condition (rather than only with respect to the same disease or condition).
(Source: Library of Congress)
Bill Actions
| Date | Description |
|---|---|
| May 11, 2022 |
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
|
| May 11, 2022 |
Introduced in the Senate by Tammy Baldwin (D-Wis.) |